HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stent implantation into the patent ductus arteriosus in cyanotic congenital heart disease with duct-dependent or diminished pulmonary circulation.

Abstract
We assessed the efficacy and safety of stent implantation into the ductus arteriosus in infants with cyanotic heart disease. Ten patients with duct-dependent or diminished pulmonary circulation underwent cardiac catheterization with the aim of stent implantation. Coronary stents of 3.5-4 mm in diameter were used and successfully implanted in eight. All patients in whom stent implantation was successful had adequate relief of their cyanosis and were discharged home. During a mean follow-up of 9.3 months (median 10 months), one patient had evidence of restenosis of the stent at five months. Re-dilatation of the stenosed stent was attempted but was unsuccessful and a modified left Blalock-Taussig shunt was placed surgically. Stent implantation of ductus arteriosus in neonates and infants with a duct-dependent pulmonary circulation is an effective and safe palliative procedure. It may be an alternative to surgical systemic-pulmonary artery shunt in a select group of patients.
AuthorsAhmet Celebi, Yalim Yalçin, Abdullah Erdem, Cenap Zeybek, Celal Akdeniz, Tuğçin Bora Polat
JournalThe Turkish journal of pediatrics (Turk J Pediatr) 2007 Oct-Dec Vol. 49 Issue 4 Pg. 413-7 ISSN: 0041-4301 [Print] Turkey
PMID18246744 (Publication Type: Journal Article)
Topics
  • Angiography
  • Cardiac Catheterization
  • Coronary Restenosis
  • Cyanosis (etiology)
  • Ductus Arteriosus, Patent (complications, therapy)
  • Fluoroscopy
  • Heart Defects, Congenital (complications, physiopathology, therapy)
  • Humans
  • Infant
  • Pulmonary Circulation
  • Stents (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: